Ebos JM - Search Results

1

Classical mathematical models for description and prediction of experimental tumor growth.

Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JM, Hlatky L, Hahnfeldt P. Benzekry S, et al. Among authors: ebos jm. PLoS Comput Biol. 2014 Aug 28;10(8):e1003800. doi: 10.1371/journal.pcbi.1003800. eCollection 2014 Aug. PLoS Comput Biol. 2014. PMID: 25167199 Free PMC article.

2

A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer.

Boland PM, Ebos JML, Attwood K, Mastri M, Fountzilas C, Iyer RV, Banker C, Goey AKL, Bies R, Ma WW, Fakih M. Boland PM, et al. Among authors: ebos jml. JNCI Cancer Spectr. 2024 Apr 30;8(3):pkae017. doi: 10.1093/jncics/pkae017. JNCI Cancer Spectr. 2024. PMID: 38697618 Free PMC article. Clinical Trial.

3

Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy.

Tracz A, Mastri M, Lee CR, Pili R, Ebos JM. Tracz A, et al. Among authors: ebos jm. J Vis Exp. 2014 Apr 29;(86):51485. doi: 10.3791/51485. J Vis Exp. 2014. PMID: 24836396 Free PMC article.

4

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy.

Ebos JM, Mastri M, Lee CR, Tracz A, Hudson JM, Attwood K, Cruz-Munoz WR, Jedeszko C, Burns P, Kerbel RS. Ebos JM, et al. EMBO Mol Med. 2014 Dec;6(12):1561-76. doi: 10.15252/emmm.201403989. EMBO Mol Med. 2014. PMID: 25361689 Free PMC article.

5

Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach.

Benzekry S, Tracz A, Mastri M, Corbelli R, Barbolosi D, Ebos JM. Benzekry S, et al. Among authors: ebos jm. Cancer Res. 2016 Feb 1;76(3):535-47. doi: 10.1158/0008-5472.CAN-15-1389. Epub 2015 Oct 28. Cancer Res. 2016. PMID: 26511632 Free PMC article.

6

The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.

Mastri M, Rosario S, Tracz A, Frink RE, Brekken RA, Ebos JM. Mastri M, et al. Among authors: ebos jm. Curr Drug Targets. 2016;17(15):1747-1754. doi: 10.2174/1389450117666151209123544. Curr Drug Targets. 2016. PMID: 26648063 Free PMC article. Review.

7

Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint Inhibitors.

Mastri M, Lee CR, Tracz A, Kerbel RS, Dolan M, Shi Y, Ebos JML. Mastri M, et al. Mol Cancer Ther. 2018 Jul;17(7):1602-1612. doi: 10.1158/1535-7163.MCT-17-1066. Epub 2018 Apr 25. Mol Cancer Ther. 2018. PMID: 29695634 Free PMC article.

8

A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal.

Mastri M, Tracz A, Lee CR, Dolan M, Attwood K, Christensen JG, Liu S, Ebos JML. Mastri M, et al. Cell Rep. 2018 Dec 26;25(13):3706-3720.e8. doi: 10.1016/j.celrep.2018.12.017. Cell Rep. 2018. PMID: 30590043 Free article.

9

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.

Dolan M, Mastri M, Tracz A, Christensen JG, Chatta G, Ebos JML. Dolan M, et al. PLoS One. 2019 Aug 1;14(8):e0220101. doi: 10.1371/journal.pone.0220101. eCollection 2019. PLoS One. 2019. PMID: 31369645 Free PMC article.

10

Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors.

Vaghi C, Rodallec A, Fanciullino R, Ciccolini J, Mochel JP, Mastri M, Poignard C, Ebos JML, Benzekry S. Vaghi C, et al. PLoS Comput Biol. 2020 Feb 25;16(2):e1007178. doi: 10.1371/journal.pcbi.1007178. eCollection 2020 Feb. PLoS Comput Biol. 2020. PMID: 32097421 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters